One in 5 parents of boys said the main reason that they haven’t vaccinated their sons for HPV was because they didn’t receive a recommendation for the vaccination, compared with 1 in 10 girls, said Anna Beavis, MD, MPH, a gynecologic oncologist fellow at Johns Hopkins University.
One in 5 parents of boys said the main reason that they haven’t vaccinated their sons for HPV was because they didn’t receive a recommendation for the vaccination, compared with 1 in 10 girls, said Anna Beavis, MD, MPH, a gynecologic oncologist fellow at Johns Hopkins University.
Transcript
What gender differences have you identified in HPV vaccination?
We did the study because we know boys are less likely to get vaccinated with the HPV vaccination compared to girls in the United States, although both are actually lagging behind the recommended vaccination rates in other westernized nations and the goal for the United States. Mainly we saw that for both, lack of necessity was a common reason as well as lack of knowledge about the vaccine.
Broken down by gender, where we saw the big differences, where that parents of boys much more commonly reported that lack of recommendation from a physician was the biggest driver. One in 5 parents of boys says the main reason that they haven’t vaccinated was because they didn’t receive a recommendation for the vaccination, compared to 1 in 10 girls. We also saw that parents of girls were more likely to report concerns about safety and side effects and a concern that their child wasn’t sexually active yet as their main reason for lack of vaccination compared to boys.
What interventions are needed to close this gap between genders?
I think the biggest intervention that providers — and that includes nurses, advanced practitioners, such as physician assistants and nurse practitioners, as well as physicians – can really do is provide a strong, clear recommendation that the vaccine provides cancer prevention, and it’s not just for girls, it’s also for boys. It is effective against cancers that affect both genders as well as cancers that specifically affect girls and women.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More